May 29, 2025 Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders C-Path, a global nonprofit accelerating drug development through data science and regulatory...
May 27, 2025 C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is
May 20, 2025 The Critical Path Institute Podcast: eCOA Conversations with Florence Mowlem, Karl McEvoy, and Brian Lillis Welcome to the latest Critical Path Institute Podcast episode—the first in the eCOA Conversations series.
May 15, 2025 From Awareness to Action: How C-Path’s HD-RSC Is Transforming the Future of Huntington’s Disease May 15, marks Huntington’s Disease Awareness Day, a key moment during Huntington’s Awareness...
May 12, 2025 C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today an $815,000 ($1,250,000 AUD) grant to Brian Dymock.
May 8, 2025 Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration The year 2025 marks a historic milestone for C-Path as the organization celebrates...
May 6, 2025 C-Path Announces First Data Transfer from Takeda to Accelerate Alpha-1 Innovation TUCSON, Ariz., May 6, 2025 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 (CPA-1) consortium is proud to ann
September 9, 2025-September 11, 2025 Registration is Now Open for the 2025 C-Path Global Impact Conference We’re excited to announce that registration is now open for the 2025 C-Path Global Impact Conference...
May 22, 2025 RDCA-DAP and NORD’s IAMRARE Platform to Platform Federation: Lessons Learned Patient data is a key asset in understanding the progression of rare diseases...
April 28, 2025 Lysosomal Storage Disease Data Sharing Webinar Series – Session #3: Retroactive Data Sharing The recent webinar from C-Path’s Critical Path for Lysosomal Diseases (CPLD) team focused on the critical issue of retroacti